As of September 2024, Alembic Pharmaceuticals has a market cap of $2.59B. This makes Alembic Pharmaceuticals the world's 4368th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.35B | 32.19% |
2023 | $1.78B | 32.55% |
2022 | $1.34B | -28.56% |
2021 | $1.88B | -22.43% |
2020 | $2.42B | 80.95% |
2019 | $1.34B | -4.74% |
2018 | $1.40B | 13.02% |
2017 | $1.24B | -10.84% |
2016 | $1.39B | -14.50% |
2015 | $1.63B | 56.36% |
2014 | $1.04B | 110.87% |
2013 | $494.08M | 191.17% |
2012 | $169.69M | 104.51% |
2011 | $82.97M | - |